EVALUATION OF TC 99M MAG3 BIOCYTIN AS HEPATOBILIARY AGENT
EVALUATION OF TC 99M MAG3 BIOCYTIN AS HEPATOBILIARY AGENT
批准号:
6161480
负责人:
JORGE A. CARRASQUILLO
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary of Work: In the course of developing a Tc-99m
radiopharmaceutical that incorporates an avidinbiotin system to detect
tumors, we have synthesized Tc-99m mercaptoacetyltriglycine-lysine-
biotin (Tc-99m MAG3-biocytin). This radiopharmaceutical was shown to be
a promising hepatobiliary agent because its hepatic uptake was not
affected by elevated levels of bilirubin. In contrast, Tc-99m disofenin,
a biliary agent of choice in clinic, shows a decreased hepatic uptake
in the presence of high levels of bilirubin, thereby making it difficult
to detect hepatic disease caused by hepatocyte dysfunction. During FY
97, we have tested the utility of this new hepatobiliary agent to
investigate the potential benefits of synthetic inhibitors of ethanol-
inducible cytochrome P450 2E1 (CYP2E1) in an acute hepatitis model
caused by a single oral administration of carbon tetrachloride (CC14)
in Balb/c mice. it was previously reported that CYP2E1 is responsible
for the metabolism of alcohol, fatty acids, acetaminophen and CC14, and
that synthetic inhibitors such as isopropyl-2-(1,3-dithioetane-2-
ylidene)-2-[N-(4-methylthiazol-2-yl)-carbamoyl] acetate (YH439) and
chlormethiazole suppress CYP2E1 gene transcription. For the studies on
acute hepatitis mice, the animals were treated with one dose of CC14
(0.25 ml/kg) 18 h before hepatobiliary scintigraphy. For the studies on
the protective effects of YH439, mice were pretreated with two doses of
YH439 (50 mg/kg/day) at 48 h and 24 h and one dose of CC14 at 18 h
before the scintigraphy. The whole-body scintigraphic data were acquired
over a course of 30 min. Time-activity curves were generated by drawing
circular regions of interest over the upper left lobe of the liver, and
also the head and neck area for the blood background. The physical
parameters, such as peak liver/heart ratio (Rmax), peak hepatic uptake
time (Tmax), and hepatic half-clearance time (HCT) were then determined
from time-activity curves. In normal mice, Tc-99m MAG3-biocytin was
taken up rapidly by liver and then excreted via biliary system (Rmax
8.3, Tmax 128 s, HCT 397 s). In mice with CC14-induced hepatotoxicity,
dynamic images showed impaired hepatic uptake with prolonged blood
background radioactivity (Rmax 1.5, Tmax 74 s, HCT 747 s). This altered
scintigraphic result was consistent with typical centrilobular necrosis
in histopathology. In contrast, treatment of YH439 not only prevented
the centrilobular necrosis but also significantly improved the kinetic
parameters (Rmax 6.2, Tmax 97 s, HCT 377 s). This study demonstrated
that the hepatotoxicity was induced by CYP2E1-mediated reaction and its
protection by CYP2E1 inhibitor could be studied in vivo using external
scintigraphic imaging methods.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RADIOLABELED MONOCLONAL ANTIBODY IMAGING OF TUMORS AND POSITRON EMISSION TOMOGRAP
-
批准号:6289424
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JORGE A. CARRASQUILLO
-
依托单位:
Radiolabeled Monoclonal Antibody Imaging Of Tumors And P
-
批准号:6675158
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JORGE A. CARRASQUILLO
-
依托单位:
Improved Tumor Targeting of Tc-99m Fab by Chemical Modifications
-
批准号:6103629
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JORGE A. CARRASQUILLO
-
依托单位:
Radiolabeled Monoclonal Antibody Imaging of Tumors and Positron Emission Tomogra
-
批准号:6431793
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JORGE A. CARRASQUILLO
-
依托单位:
Chemical Modifications of Antibodies for Tumor Targeting
-
批准号:6431804
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JORGE A. CARRASQUILLO
-
依托单位:
Radiolabeled Monoclonal Antibody Imaging of Tumors and Positron Emission Tomograp
-
批准号:6103612
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JORGE A. CARRASQUILLO
-
依托单位:
Monoclonal Antibody Imaging Of Tumors And Positron Emmis
-
批准号:7212401
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JORGE A. CARRASQUILLO
-
依托单位:
Radiolabeled Monoclonal Antibody Imaging Of Tumors & PET
-
批准号:6844208
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JORGE A. CARRASQUILLO
-
依托单位:
RADIOLABELED MONOCLONAL ANTIBODY IMAGING OF TUMORS
-
批准号:6161460
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JORGE A. CARRASQUILLO
-
依托单位:
Radiolabeled Monoclonal Antibody Imaging Of Tumors And P
-
批准号:7331893
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JORGE A. CARRASQUILLO
-
依托单位:
ENHANCEMENT OF RENAL CLEARANCE OF TC 99M DSFV BY CHEMICAL MODIFICATIONS
-
批准号:6161479
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JORGE A. CARRASQUILLO
-
依托单位:
Radiolabeled Monoclonal Antibody Imaging Of Tumors And P
-
批准号:6542067
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JORGE A. CARRASQUILLO
-
依托单位:
IMPROVED TUMOR TARGETING OF TC-99M FAB BY CHEMICAL MODIFICATIONS
-
批准号:6289431
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JORGE A. CARRASQUILLO
-
依托单位:
海外基金